Prometheon's CEO/CSO Delivers Oral Presentation at the European Society for Paediatric Endocrinology Meeting (Dublin)


Dr.Stephen Hsu (CEO/CSO) presented on Prometheon R&D team's history-making studies of an optimized TopiconENDO™ human growth hormone patch formulation for needle-free extended-wear hormone replacement therapy in children and adults. He delivered his oral presentation at Europe's most prestigious international gathering of pediatric endocrinologists and scientists--the 53rd Annual ESPE Meeting (Dublin, Ireland). He has been invited to serve as an abstract reviewer for the 54th Annual ESPE Meeting (Barcelona, Spain).